Der wichtigste Partner für Kapitel TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES; PRODUCTS, WHETHER OR NOT CONTAINING NICOTINE, INTENDED FOR INHALATION WITHOUT COMBUSTION; OTHER NICOTINE CONTAINING PRODUCTS INTENDED FOR THE INTAKE OF NICOTINE INTO THE HUMAN BODY ist 🇯🇵 Japan mit einem Volumen von €427.7M im Zeitraum Jan-Mär 2026.
Kapitel TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES; PRODUCTS, WHETHER OR NOT CONTAINING NICOTINE, INTENDED FOR INHALATION WITHOUT COMBUSTION; OTHER NICOTINE CONTAINING PRODUCTS INTENDED FOR THE INTAKE OF NICOTINE INTO THE HUMAN BODY weist einen Überschuss von €498.2M auf (Jan-Mär 2026). Die EU importiert €1.4B und exportiert €1.9B.
Das wichtigste NC8-Produkt in Kapitel TOBACCO AND MANUFACTURED TOBACCO SUBSTITUTES; PRODUCTS, WHETHER OR NOT CONTAINING NICOTINE, INTENDED FOR INHALATION WITHOUT COMBUSTION; OTHER NICOTINE CONTAINING PRODUCTS INTENDED FOR THE INTAKE OF NICOTINE INTO THE HUMAN BODY ist Flue-cured tobacco (24012085) mit einem Volumen von €596.8M im Zeitraum Jan-Mär 2026.
Quelle: Eurostat Comext
| 6 |
| 🇲🇼MW |
| €101.8M |
| €0 |
| €101.8M |
| 7 | 🇳🇴Norway | €341K | €101.1M | €101.5M |
| 8 | 🇽🇸XS | €46.6M | €53.7M | €100.3M |
| 9 | 🇨🇭Switzerland | €20.5M | €75.6M | €96.2M |
| 10 | 🇹🇿TZ | €92.0M | €26K | €92.0M |
| 11 | 🇺🇸United States | €41.3M | €49.4M | €90.7M |
| 12 | 🇮🇳India | €84.8M | €872K | €85.7M |
| 13 | 🇶🇼QW | €11.6M | €65.4M | €77.0M |
| 14 | 🇿🇼ZW | €76.5M | €711 | €76.5M |
| 15 | 🇷🇺Russia | €2.9M | €64.1M | €67.0M |
| 16 | 🇲🇿MZ | €63.3M | €0 | €63.3M |
| 17 | 🇪🇬Egypt | €76K | €59.1M | €59.2M |
| 18 | 🇮🇩Indonesia | €38.3M | €14.2M | €52.5M |
| 19 | 🇺🇦Ukraine | €59K | €50.4M | €50.4M |
| 20 | 🇦🇪United Arab Emirates | €177K | €41.7M | €41.9M |
| 21 | 🇧🇩Bangladesh | €39.1M | €223 | €39.1M |
| 22 | 🇲🇰North Macedonia | €29.5M | €6.6M | €36.1M |
| 23 | 🇨🇦Canada | €596K | €32.4M | €33.0M |
| 24 | 🇯🇴Jordan | €3.9M | €28.4M | €32.3M |
| 25 | 🇦🇱Albania | €3.7M | €28.6M | €32.3M |
| 26 | 🇿🇲ZM | €31.6M | €300 | €31.6M |
| 27 | 🇸🇦Saudi Arabia | €3K | €30.9M | €30.9M |
| 28 | 🇵🇭Philippines | €14.8M | €15.2M | €30.0M |
| 29 | 🇨🇮CI | €0 | €30.0M | €30.0M |
| 30 | 🇩🇿Algeria | €2K | €29.7M | €29.7M |
| €48.0M |
| €289.5M |
| 5 | Other, containing nicotine | €280.0M | €8.6M | €288.6M |
| 6 | Cigars, cheroots and cigarillos, containing tobacco | €71.4M | €59.6M | €131.0M |
| 7 | Other | €5.0M | €105.7M | €110.6M |
| 8 | Other | €5.4M | €97.6M | €102.9M |
| 9 | Nicotine containing products intended to assist tobacco use cessation | €12.1M | €90.7M | €102.8M |
| 10 | In immediate packings of a net content not exceeding 500|g | €315K | €100.4M | €100.7M |
| 11 | Other | €21.5M | €69.4M | €90.8M |
| 12 | Sun-cured Oriental type tobacco | €46.3M | €27.8M | €74.1M |
| 13 | Other | €3.1M | €69.5M | €72.7M |
| 14 | Chewing tobacco and snuff (nasal tobacco) | €6.8M | €39.7M | €46.5M |
| 15 | Tobacco refuse | €25.9M | €2.9M | €28.8M |
| 16 | Dark air-cured tobacco | €25.1M | €70K | €25.2M |
| 17 | Other | €8.7M | €15.5M | €24.2M |
| 18 | Other | €18.6M | €4.9M | €23.4M |
| 19 | Flue-cured tobacco | €11.4M | €5.7M | €17.2M |
| 20 | For transdermal application | €30K | €11.2M | €11.2M |